SFSLF yields 2.76% · PFE yields 6.13%● Live data
📍 SFSLF pulled ahead of the other in Year 1
Combined, SFSLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SFSLF + PFE for your $10,000?
SFS Group AG supplies mechanical fastening systems, assemblies, precision molded parts, and logistics solutions internationally. It offers airbag restraint systems; automation; bracket logic concept; brake systems; building technologies; clip nuts; communication technologies; components, assemblies, and complete devices; connections and reinforcements for timber construction; and domestic and kitchen appliances. The company also provides fasters for inserts; fastening and hinge technology for doors, windows, and glass facades; fastening system for the façade; furniture fittings; hand driving tools and wrenches; hard disk drives; inserts; interior plastics; life-saving fall protection; lifestyle electronics; mobile devices; sensors; seats and doors; connections and reinforcements for structural timber construction; tools, forest and garden equipment; wire and hypotubing; and window fittings. It offers its products to the aircraft, automotive, construction, electronics, medical, and other markets. SFS Group AG was founded in 1928 and is headquartered in Heerbrugg, Switzerland.
Full SFSLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.